Ultragenyx Pharmaceutical, Inc. (RARE)

23.38 -0.69 (-2.87%) USD  |  NASDAQ  |  Jan 15, 11:19
More

Ultragenyx Pharmaceutical Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Johnson & Johnson Upgrade
CorMedix, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Insmed, Inc. Upgrade